Synsory Bio develops advanced protein therapeutics that target diseased tissues, enhancing the efficacy of potent drugs for cancer and autoimmune disorders.
Founded
2023
Company Stage
Seed
Investors
Y Combinator
YC Batch
W24
Product Features & Capabilities
next-generation protein therapeutics, synthetic sensing functions, conditional activation upon sensing disease markers, targeted activation at diseased tissue, potential applications in cancer and autoimmune disorders
